Discover why LeMaitre's expansion in the peripheral vascular disease market and strong dividend growth make it an appealing ...

Medtronic and Volcano Corporation. Peripheral vascular devices Market Outlook Peripheral vascular devices are gadgets used in the diagnosis and management of diseases of the blood vessels other ...

In the peripheral vascular devices market, Medtronic plays a pivotal role by offering a wide range of products designed to treat peripheral artery disease (PAD), deep vein thrombosis (DVT), and ...

A recently unsealed lawsuit alleges sales reps from Medtronic, the world’s largest medical equipment company, operated a bribery scheme at a Kansas hospital.

Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.

Needham analyst Michael Matson has maintained their neutral stance on MDT stock, giving a Hold rating today. Michael Matson’s rating is ...

Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Lemaitre Vascular (LMAT – Research Report) today and set a price target of ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G ...